SurgePays
SURG
#9947
Rank
NZ$64.1 M
Marketcap
NZ$3.05
Share price
1.73%
Change (1 day)
0.68%
Change (1 year)

Market capitalization of SurgePays (SURG)

Market cap: NZ$64.1 Million

As of December 2025 SurgePays has a market cap of NZ$64.1 Million. This makes SurgePays the world's 9947th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of SurgePays from 2008 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$64.1 M-2.01%
2024NZ$65.42 M-54.92%
2023NZ$0.14 B12.08%
2022NZ$0.12 B262.9%
2021NZ$35.67 M72.33%
2020NZ$20.7 M-54.52%
2019NZ$45.52 M-8.74%
2018NZ$49.87 M-46.61%
2017NZ$93.41 M323.05%
2016NZ$22.08 M-7.05%
2015NZ$23.75 M8535.24%
2014NZ$0.27 M49.83%
2013NZ$0.18 M
2011NZ$1.38 M53.28%
2010NZ$0.9 M-32.08%
2009NZ$1.32 M-95.14%
2008NZ$27.3 M

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of SurgePays was reported to be:

NZ$64.1 Million
by Nasdaq info icon info icon
NZ$64.1 Million
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
STAAR Surgical
STAA
NZ$2.16 B 3,283.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Integra LifeSciences
IART
NZ$1.78 B 2,685.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Cooper Companies
COO
NZ$28.11 B 43,753.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Stryker Corporation
SYK
NZ$240.97 B 375,807.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$842.14 B 1,313,618.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$438.96 B 684,661.75%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
CONMED
CNMD
NZ$2.14 B 3,250.76%๐Ÿ‡บ๐Ÿ‡ธ USA